Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
medicare
regeneron pharmaceuticals
alex azar
alirocumab
alnylam pharmaceuticals
ambys medicines
american patients first
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
bill &
What
drug
long
4
×
prices
4
×
awaited
details
drugs
house
lower
plan
prescription
actor
afternoon
anathema
anticipated
aren’t
balk
billion
bio
blueprint
chance
clinical
companies
cost
cut
democrat
developers
development
dollar
drug's
elements
fda
gave
gene
help
imminent
leaked
look
lot
make
martin
Language
unset
Current search:
prices
×
long
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@WIRED
8 years ago
Long before you ever have a chance to balk at prescription drug prices, the companies that make the medicine rack up billion-dollar tabs from research, ...
